FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 0832-0038 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA074625
Dosage form / routeTABLET · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started20111107
Marketing ended20281231
Package count4

External sources

Source: openFDA. Public-domain (CC0).